Table 1.
Parameter | Value |
---|---|
Age, y | 62.2 ± 13.1 |
BMI, kg/m2 | |
Median | 23.3 |
IQR | 23.0-30.4 |
ASA classification | |
I | 47 (21.7) |
II | 130 (59.9) |
III | 40 (18.4) |
National screening program diagnosis | 55 (25.7) |
T stage | |
T0 | 28 (13.5) |
T1 | 119 (57.5) |
T2 | 50 (24.2) |
T3 | 6 (2.9) |
T4 | 4 (1.9) |
Data missing | 10 (4.6) |
N stage | |
N0 | 147 (71.0) |
N1 | 49 (23.7) |
N2 | 7 (3.4) |
N3 | 4 (1.9) |
Data missing | 10 (4.6) |
M stage | 0 (0.0) |
Neoadjuvant therapy | 61 (28.1) |
Adjuvant therapy | 170 (78.3) |
Type of surgery | |
BCT | 139 (64.1) |
Mastectomy | 63 (29.3) |
Other | 15 (6.9) |
Patients tested for COVID-19 | 21 (9.7) |
Complications | |
None | 199 (91.7) |
Minor | 10 (4.6) |
Major | 8 (3.7) |
Data presented as mean ± standard deviation or n (%), unless noted otherwise.
Abbreviations: ASA = American Society of Anesthesiologists; BCT = breast conserving therapy; BMI = body mass index; COVID-19 = coronavirus disease 2019; IQR = interquartile range.